NCT02817373

Brief Summary

This study is designed to predict implantation of a fresh, high quality embryo in an in vitro fertilization (IVF) cycle by using ultrasound based uterine factors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 29, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 30, 2016

Status Verified

December 1, 2016

Enrollment Period

1.7 years

First QC Date

June 20, 2016

Last Update Submit

December 29, 2016

Conditions

Keywords

IVFembryo transferultrasoundimplantation

Outcome Measures

Primary Outcomes (1)

  • implantation of a fresh high quality embryo

    Implantation is defined as the presence of a gestational sac as will be assessed by a vaginal ultrasound probe 4 weeks after the embryo transfer. Implantation is expected to exist only in cases of a positive pregnancy test; in such cases the ultrasound can either describe an absence of sac, a single sac or multiple sacs.

    outcome measure will be known within 4 weeks of the embryo transfer

Study Arms (1)

transvaginal ultrasound study

OTHER

Patients with a well established infertility requiring IVF treatment and who are \<40. Cohort will consist of patients going through a fresh day 5 transfer with a planned transfer of a single good quality embryo. Patients will go thorough a Ultrasound scan performed through a vaginal probe on the morning of the embryo transfer.

Other: Ultrasound scan performed through a vaginal probe

Interventions

5-8 minute scan recording : endometrial thickness, endometrial pattern, endometrial -myometrial junction appearance, subendometrial wave contractions (presence and number), endometrial surface area

transvaginal ultrasound study

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Single day 5 fresh embryo transfer of good quality
  • Age\<40

You may not qualify if:

  • Frozen embryo transfer
  • Age\>40
  • Day 2-3 transfer
  • Double embryo transfer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center

Kfar Saba, Israel, Israel

RECRUITING

Related Publications (3)

  • Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 Dec;49(12):1373-9. doi: 10.1016/s0895-4356(96)00236-3.

    PMID: 8970487BACKGROUND
  • Matsuura K, Hayashi N, Takiue C, Hirata R, Habara T, Naruse K. Blastocyst quality scoring based on morphologic grading correlates with cell number. Fertil Steril. 2010 Aug;94(3):1135-7. doi: 10.1016/j.fertnstert.2009.11.003. Epub 2010 Jan 15.

  • Hershko-Klement A, Tepper R. Ultrasound in assisted reproduction: a call to fill the endometrial gap. Fertil Steril. 2016 Jun;105(6):1394-1402.e4. doi: 10.1016/j.fertnstert.2016.04.012. Epub 2016 Apr 29.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Amir Wiser, MD

    Meir Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anat Hershko Klement, MD

CONTACT

Amir Wiser, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2016

First Posted

June 29, 2016

Study Start

November 1, 2016

Primary Completion

August 1, 2018

Study Completion

December 1, 2018

Last Updated

December 30, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations